Pa Shun International Holdings Limited (HK:0574)
:0574
Top Page
Pa Shun International Holdings Limited
(0574)
Select Model
Select Model
Rating:47Neutral
Price Target:
HK$0.06
▲(24.00% Upside)
Action:ReiteratedDate:02/03/26
The score is held down primarily by very weak financial performance (declining revenue, ongoing losses, negative equity, and negative free cash flow). Technicals are supportive in the short term (price above major moving averages and positive MACD) but are tempered by overbought signals (high RSI and Stochastic). Valuation provides limited support because the negative P/E reflects unprofitability and no dividend yield is available.
Positive Factors
Industry Exposure
Operating in Medical - Pharmaceuticals provides structurally steady end-market demand and regulatory entry barriers that can sustain long-term revenue opportunity versus cyclical sectors, supporting durable product demand and potential margin resilience over multiple years.
Negative Factors
Declining Revenue Trend
Material multi-year revenue decline erodes scale, reduces pricing leverage and increases unit costs, making margin recovery harder. Sustained top-line contraction weakens competitive position and limits reinvestment capacity for R&D or commercial expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Industry Exposure
Operating in Medical - Pharmaceuticals provides structurally steady end-market demand and regulatory entry barriers that can sustain long-term revenue opportunity versus cyclical sectors, supporting durable product demand and potential margin resilience over multiple years.
Read all positive factors
Pa Shun International Holdings Limited (0574) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$57.52M
Dividend YieldN/A
Average Volume (3M)1.15M
Price to Earnings (P/E)―
Beta (1Y)0.28
Revenue Growth-9.71%
EPS Growth-279.92%
CountryHK
Employees97
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,474,992,900
10 Day Avg. Volume798,200
30 Day Avg. Volume1,152,533
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.48
Price to Sales (P/S)0.75
P/FCF Ratio-36.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pa Shun International Holdings Limited Business Overview & Revenue Model
Company Description
Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution activities in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Self-Operated Retail P...
How the Company Makes Money
Pa Shun International Holdings Limited generates revenue through multiple streams, primarily from the sale of its manufactured consumer goods, including electronics and home appliances. The company operates on a business model that involves design...
Pa Shun International Holdings Limited Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
20
Very Negative
Cash Flow
30
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 86.42M | 86.55M | 129.43M | 71.78M | 85.91M | 474.83M |
| Gross Profit | 13.74M | 17.06M | 29.43M | 13.30M | 11.06M | 17.70M |
| EBITDA | 99.00K | 2.89M | 19.65M | -3.26M | -11.85M | -11.10M |
| Net Income | -59.80M | -15.31M | 2.35M | -43.38M | -330.40M | -419.19M |
Balance Sheet | ||||||
| Total Assets | 161.96M | 179.65M | 206.57M | 136.09M | 468.59M | 503.19M |
| Cash, Cash Equivalents and Short-Term Investments | 3.56M | 15.97M | 16.51M | 1.90M | 2.27M | 5.26M |
| Total Debt | 40.42M | 44.03M | 165.97M | 108.71M | 99.01M | 102.71M |
| Total Liabilities | 310.43M | 315.68M | 322.67M | 251.60M | 251.59M | 225.20M |
| Stockholders Equity | -148.47M | -136.04M | -116.10M | -115.52M | -58.50M | 277.98M |
Cash Flow | ||||||
| Free Cash Flow | 5.39M | -1.77M | -35.00M | -2.35M | -22.12M | -6.59M |
| Operating Cash Flow | 5.49M | -1.68M | -34.93M | -2.32M | -21.89M | -6.51M |
| Investing Cash Flow | -596.00K | -88.00K | -65.00K | 2.98M | 24.97M | -2.43M |
| Financing Cash Flow | -5.96M | 1.23M | 49.61M | -1.02M | -6.07M | 3.17M |
Pa Shun International Holdings Limited Technical Analysis
Negative
0.05
Price Trends
0.05
Negative
0.05
Negative
0.05
Negative
Market Momentum
>-0.01
Positive
28.89
Positive
40.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0574, the sentiment is Negative. The current price of 0.05 is above the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 28.89 is Positive, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0574.
Pa Shun International Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
58 Neutral | HK$56.73M | 362.73 | -19.93% | ― | -2.91% | 55.41% | |
54 Neutral | HK$126.61M | -18.49 | -17.12% | ― | -4.50% | 75.98% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$44.90M | 7.84 | -3.06% | ― | -40.37% | -112.64% | |
47 Neutral | HK$57.52M | -1.08 | 42.03% | ― | -9.71% | -279.92% |
* Healthcare Sector Average
HK:0574
Pa Shun International Holdings Limited
0.04
<0.01
5.41%
HK:1889
Sanai Health Industry Group Company Limited
0.32
0.01
3.23%
HK:0911
Qianhai Health Holdings Ltd.
0.27
0.04
15.22%
HK:0401
Wanjia Group Holdings Ltd.
0.11
0.07
151.11%
HK:6108
New Ray Medicine International Holding Ltd.
0.20
-0.24
-54.77%
HK:8307
Medicskin Holdings Ltd.
0.14
>-0.01
-4.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.